1.Aldámiz-Echevarría L，Llarena M，Bueno MA，et al. Molecular epidemiology，genotype-phenotype correlation and BH₄ responsiveness in Spanish patients with phenylketonuria.J Hum Genet，2016，Apr 28.

2.Bijvoet GP，van der Sijs-Bos CJ，Wielders JP，et al.Fatal hyperammonaemia due to late-onset ornithine transcarbamylase deficiency.Neth J Med，2016，74：36-39

3.Chin HL，Aw MM，Quak SH，et al. Two consecutive partial liver transplants in a patient with Classic Maple Syrup Urine Disease.Mol Genet Metab Rep，2015，4：49-52.

4.Caterino M，Chandler RJ，Sloan JL，et al. The proteome of methylmalonic acidemia（MMA）：the elucidation of altered pathways in patient livers.Mol Biosyst，2016，12：566-574.

5.Fujisawa D，Nakamura K，Mitsubuchi H，et al.Clinical features and management of organic acidemias in Japan.J Hum Genet，2013，58：769-774.

6.Hartung B，Temme O，Neuen-Jacob E，et al.Ornithine transcarbamylase deficiency of a male newborn with fatal outcome.Int J Legal Med，2016，130：783-785.

7.Han B，Cao Z，Tian L，et al. Clinical presentation，gene analysis and outcomes in young patients with early-treated combined methylmalonic acidemia and homocysteinemia（cblC type）in Shandong province.China.Brain Dev，2016 38：491-497.

8.Han LS，Huang Z，Han F，et al. Clinical features and MUT gene mutation spectrum in Chinese patients with isolated methylmalonic acidemia：identification of ten novel allelic variants.World J Pediatr，2015，11：358-365.

9.Kölker S，Garcia-Cazorla A，Valayannopoulos V，The phenotypic spectrum of organic acidurias and urea cycle disorders.Part 1：the initial presentation.J Inherit Metab Dis，2015，38：1041-1057.

10.Linari S，Castaman G.Clinical manifestations and management of Gaucher disease.Clin Cases Miner Bone Metab，2015，12：157-164.

11.Mohamed S，Hamad MH，Kondkar AA，et al. A novel mutation in ornithine transcarbamylase gene causing mild intermittent hyperammonemia.Saudi Med J，2015，36：1229-1232.

12.Martinez Alvarez L，Jameson E，Parry NR，et al.Optic neuropathy in methylmalonic acidemia and propionic acidemia.Br J Ophthalmol，2016，100：98-104.

13.Qi YH，Qi JG，Liu YP，et al. Clinical analysis and follow-up study of cardiavascular system involvement in 10 children with methylmalonic aciduria combined with hyperhomocysteinemia］.Zhongguo Dang Dai Er Ke Za Zhi，2015，17：965-970.

14.Shennar HK，Al-Asmar D，Kaddoura A，et al. Diagnosis and clinical features of organic acidemias：A hospital-based study in a single center in Damascus，Syria.Qatar Med J，2015 Jul 4；2015（1）：9.

15.Singh A，Lomash A，Pandey S，et al. Clinical，Biochemical and Outcome Profile of Biotinidase Deficient Patients from Tertiary Centre in Northern India.J Clin Diagn Res，2015，9：SC08-10.

16.Sentner CP，Hoogeveen IJ，Weinstein DA，et al.Glycogen storage disease type III：diagnosis，genotype，management，clinical course and outcome.J Inherit Metab Dis，2016 Apr 22.

17.Tebani A，Zanoutene-Cheriet L，Adjtoutah Z，et al.Clinical and Molecular Characterization of Patients with Mucopolysaccharidosis Type I in an Algerian Series.Int J Mol Sci，2016 May 17；17（5）.

18.Talebi H，Yaghini O.Auditory Neuropathy/Dyssynchrony in Biotinidase Deficiency.J Audiol Otol，2016，20：53-54.

19.Vatanavicharn N，Liammongkolkul S，Sakamoto O，et al. Clinical characteristics and mutation analysis of propionic acidemia in Thailand.World J Pediatr，2014，10：64-68.

20.Wang Q，Ding Y，Liu Y，et al. Clinical and laboratory studies on 28 patients with glutaric aciduria type 1.Zhonghua Er Ke Za Zhi，2014，52：415-419.

21.Wu TF，Yang YL.Advances in clinical and molecular genetics studies on argininemia.Zhongguo Dang Dai Er Ke Za Zhi，2013，15：954-959.

22.Yamada K，Kobayashi H，Bo R，et al. Clinical，biochemical and molecular investigation of adultonset glutaric acidemia type II：Characteristics in comparison with pediatric cases.Brain Dev，2016，38：293-301.